Bryan Daniel Baum
CIK: 0002077411
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNTI
Senti Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
About Baum Bryan Daniel
Baum Bryan Daniel (SEC CIK 0002077411) files insider reports with the SEC as Director of Senti Biosciences, Inc. (SNTI).
Signal8 holds 2 ownership filings by Baum Bryan Daniel (1 Form 3, 1 Form 4), filed on Jul 21, 2025. Those filings report 1 transaction, the latest on Jul 18, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Baum Bryan Daniel's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by Baum Bryan Daniel
- Jul 18, 2025: Grant or award of SNTI derivative securities (Form 4, code A).
Other insiders filing for Senti Biosciences, Inc. (SNTI)
- Rajangam Kanya, Pres. & Chief Med. & Dev. Off.
- Lu Timothy K, CEO
- Collins James J., Director
- Hsiung Feng, Director
- Schulz Fran, Director
- COOPERSTONE BRENDA, Director